BMPR2 mutations have been associated with the pulmonary-artery-hyperproliferative and apoptosis-resistant phenotype that leads to vascular remodeling; however, there is also a reduction in BMPR2 expression in other forms of PAH not associated with clear mutations [66]. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.